With the start of 2022, ARCHIMEDlife is pleased to announce that we will be once again attending in-person conferences!
The WORLDSymposium for lysosomal disease research will be a live event from 7 February to 11 February 2022 in San Diego, California USA. ARCHIMEDlife is proud to be participating again as a gold-level sponsor. If you are able to attend the conference, come visit us in Booth 609.
Our team will be presenting seven posters and delivering two oral presentations.
Posters
- Rapid identification of IOPD and early-onset Pompe disease by biochemical enzymatic testing. Monday Session, Poster 19
- Alpha-mannosidosis is an underdiagnosed lysosomal disease. Monday Session, Poster 274
- High-risk population screening by differential diagnosis for mucopolysaccharidoses (MPSs). Monday Session, Poster 275
- Prospective of newborn screening and rare disease diagnostic initiatives in Europe. Thursday Session, Poster 195
- Diagnostic strategy for suspected cases of Fabry disease. Thursday Session, Poster 220
- Differential diagnosis of Niemann-Pick disease type A/B in cases of suspected Gaucher disease. Thursday Session, Poster 221
- Newborn screening for metachromatic leukodystrophy in northern Germany. Thursday Session, Poster 222
Presentations
- Rapid identification of IOPD and early-onset Pompe disease by biochemical enzymatic testing. Monday Session 13:00
- High-risk population screening by differential diagnosis for mucopolysaccharidoses (MPSs). Friday Session 11:15